US 10604537
Solid state forms of ixazomib citrate
granted A61KA61K31/69A61P
Quick answer
US patent 10604537 (Solid state forms of ixazomib citrate) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/69, A61P, A61P35/00